Comparison of Ixekizumab and Ustekinumab Efficacy in the Treatment of Nail Lesions of Patients With Moderate-to-Severe Plaque Psoriasis: 52-Week Data From the IXORA-S Trial

Main Article Content

Norman Wasel
Yves Dutronc
Birgit Schinzel
Jean-Philippe Lacour

Keywords

Abstract

Abstract not available.

 

Disclosures: Study sponsored by Eli Lilly & Company.

 

Copyright 2018 SKIN